Navigating the Grey Zone for Antenatal Corticosteroids

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

460 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-20

Study Completion Date

2024-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of a Booster Course of Antenatal Steroids on Neonatal Outcome in Patients With Premature Rupture of the Membranes

NCT02469519

Premature Birth

COMPLETED PHASE2/PHASE3

Antenatal Rescue Course of Glucocorticoids in Threatened Premature Birth

NCT00295464

Respiratory Distress Syndrome Intraventricular Haemorrhage

TERMINATED PHASE4

Effectiveness of ACS in Extreme Preemies

NCT02351310

Preterm Labor Premature Birth

WITHDRAWN PHASE3

A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome

NCT00201643

Preterm Delivery

COMPLETED PHASE4

Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm Birth

NCT04494529

Preterm Birth Complication of Prematurity Obstetric Labor, Premature +2 more

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Decision Making, Shared Pregnancy Preterm Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Controlled before and after study

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Guideline + decision support tool

A decision support tool summarizing harms and benefits of late preterm antenatal corticosteroids will be integrated into the clinical practice guideline available to clinicians in the hospitals in the experimental arm.

Group Type EXPERIMENTAL

Decision support tool

Intervention Type BEHAVIORAL

Decision support tool for late preterm antenatal corticosteroids

Guideline only

Clinicians in the hospitals in the 'no-intervention' arm will have access to the standard guideline only (without the integrated decision support tool).

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Decision support tool

Decision support tool for late preterm antenatal corticosteroids

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 year or older.
* Delivered a live neonate at 34+0 to 36+6 weeks of gestation.
* Speaks English.
* Agrees to participate in the questionnaire during their first week post-partum.
* Delivered at one of the six participating obstetrical hospitals.